Research study Program year 2021 Source: CMS Open Payments

A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov NCT03495102

Research payments

$5,390,450

363 payments

Through program year 2021, $5,390,450 in research payments was reported against A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus, across 363 payments.

Paid by (largest first)
Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
ClinicalTrials.gov
NCT03495102

By program year

3 rows
Year Kind Amount Payments
2021 Research $6,515 5
2020 Research $85,069 98
2019 Research $5,298,866 260

Breakdown

Who paid Research payments · program years 2019–2021
  1. Eli Lilly and Company $5,051,326 353 payments
  2. Eli Lilly Export S.A. Puerto Rico Branch $339,124 10 payments
Who received the money Research payments · program years 2019–2021
  1. Andrew J Lewin Med Dba National Rsrch Institute Organisation paid for research $442,632 10 payments
  2. Suncoast Research Organisation paid for research $303,548 4 payments
  3. New Horizon Research Center Organisation paid for research $233,637 5 payments
  4. Artemis Institute For Clinical Research LLC Organisation paid for research $172,768 3 payments
  5. Catalina Research Institute LLC Organisation paid for research $168,538 5 payments
  6. Gcm Medical Group Psc Organisation paid for research $159,153 4 payments
  7. Pharmaseek Financial Services Llc Organisation paid for research $149,936 3 payments
  8. Clinical Research Advantage Organisation paid for research $126,887 6 payments
  9. Burke Internal Medicine Inc, Dba Manassas Clinical Research Cent Organisation paid for research $118,474 4 payments
  10. Arcturus Healthcare Plc, Troy Internal Organisation paid for research $112,541 4 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record